Real-world efficacy of oral upadacitinib for vitiligo and factors associated with treatment response: A retrospective study.

Liu Y, Shi X, Yuan Y, Sun R, Du J, Wang F, Ding X
JAAD international · 2026 · doi:10.1016/j.jdin.2026.04.016 · PMID:42292073 · PMC13264083
OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-18 ⓘ

This retrospective study evaluated the real-world efficacy of oral upadacitinib for vitiligo and identified factors associated with treatment response.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC